On Nov 4, 2021 MigVax closed a Grant round and raised $3,400,000 from Coalition for Epidemic Preparedness Innovations, featuring lead investors Coalition for Epidemic Preparedness Innovations.

About the company: MigVax is located at Israel, Asia.
“MigVax, a SPV by MIGAL is developing a vaccine for COVID-19, Coronavirus in human. ”

Company website: http://www.migvax.com